Jens Lichtenberg
Novozymes
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jens Lichtenberg.
Journal of Bone and Mineral Research | 2004
Sophie Schaller; Kim Henriksen; Christina Sveigaard; Anne-Marie Heegaard; Nathalie Hélix; Martin Stahlhut; Maria del Carmen Ovejero; Jens V Johansen; Helene Solberg; Thomas Levin Andersen; Dorit Hougaard; Mark Berryman; Christine B Shiødt; Bjørn H Sørensen; Jens Lichtenberg; Palle Christophersen; Niels T. Foged; Jean-Marie Delaissé; Michael Thyrring Engsig; Morten A. Karsdal
Chloride channel activity is essential for osteoclast function. Consequently, inhibition of the osteoclastic chloride channel should prevent bone resorption. Accordingly, we tested a chloride channel inhibitor on bone turnover and found that it inhibits bone resorption without affecting bone formation. This study indicates that chloride channel inhibitors are highly promising for treatment of osteoporosis.
Pharmacology & Toxicology | 1999
Jens Lichtenberg; Pernille-Julia Vig Hjarnaa; Paul E. G. Kristjansen; Dann Hansen; Lise Binderup
Pharmacology & Toxicology | 1997
Jens Lichtenberg; Hansen Ca; Skak-Nielsen T; Bay C; Jens Thing Mortensen; Lise Binderup
Archive | 2003
Jens Lichtenberg; Palle Christophersen; Bjarne H. Dahl
Archive | 2017
Nils Brünner; Palle Christophersen; Jan Stenvang; Jens Lichtenberg; Annemette Thougaard
Toxicology Letters | 2006
Jens Lichtenberg; Inge Birgit Jørgensen; Ninna Willestofte Berg
Toxicology Letters | 2003
Jens Lichtenberg; Palle Christophersen
Archive | 2003
Jens Lichtenberg; Palle Christophersen; Bjarne H. Dahl
Archive | 2003
Jens Lichtenberg; Palle Christophersen; Bjarne H. Dahl
Toxicology Letters | 1996
Jens Lichtenberg; Christian A. Hansen; Dann Hansen; Jeanette Juul; Jens Thing Mortensen; Lise Binderup
